C07K 4/00
Peptides having up to 20 amino acids in an undefined or only
Official title: Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
C07K4/00 (Peptides having up to 20 amino acids in an undefined or only) appears on 162 US grants and 215 published applications in this corpus.
Search patents in C07K- Granted patents
- 162
- Published applications
- 215
- Assignees
- 182
- Inventors
- 520
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 2 | 0 |
| 1979 | 4 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 5 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 1 | 2 |
| 2008 | 1 | 5 |
| 2009 | 1 | 2 |
| 2010 | 1 | 3 |
| 2011 | 2 | 7 |
| 2012 | 2 | 11 |
| 2013 | 4 | 7 |
| 2014 | 14 | 18 |
| 2015 | 8 | 11 |
| 2016 | 11 | 11 |
| 2017 | 9 | 8 |
| 2018 | 8 | 19 |
| 2019 | 4 | 19 |
| 2020 | 14 | 19 |
| 2021 | 11 | 14 |
| 2022 | 7 | 8 |
| 2023 | 13 | 13 |
| 2024 | 3 | 12 |
| 2025 | 8 | 13 |
| 2026 | 4 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Procoagulant peptides and use thereof21 Jul 2026US 12,686,704 B2Rambam Med-Tech Ltd.
- GLP-1/GIP dual agonists12 May 2026US 12,622,948 B2Sun Pharmaceutical Industries Limited
- Biomarkers and methods for predicting preterm birth14 Apr 2026US 12,601,744 B2Sera Prognostics, Inc.
- Methods and compositions for delivery of biotin to mitochondria24 Feb 2026US 12,558,346 B2Social Profit Network
- Methods for treating breast cancer and for identifying breast cancer antigens4 Nov 2025US 12,461,110 B2University of Connecticut
- Soybean allergy antigen27 Aug 2026US 2026/0248910 A1Hoyu Co., Ltd.
- Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response27 Aug 2026US 2026/0248912 A1Barinthus Biotherapeutics North America, Inc.
- Gdnf mimetic peptide amphiphiles9 Jul 2026US 2026/0192016 A1Northwestern University
- Class of polypeptides targeting protein degradation and application thereof9 Jul 2026US 2026/0193296 A1Institute of Microbiology, Chinese Academy of Sciences
- Peptide-type nucleic acid carrier, gene therapeutic composition including it and use thereof19 Mar 2026US 2026/0077058 A1National Cheng Kung University
Most cited
By later US patents
- Triazole macrocycle systems50US 7,981,999 B2Aileron Therapeutics, Inc. · 2011
- Transcutaneous delivery of therapeutic agents49US 8,728,491 B2Alba Therapeutics Corporation · 2014
- Nucleosides with antiviral and anticancer activity43US 8,399,428 B2Regents of the University of Minnesota · 2013
- Peptide vaccines for cancers expressing tumor-associated antigens39US 9,284,349 B2Oncotherapy Science, Inc. · 2016
- Triazole macrocycle systems37US 8,637,686 B2Aileron Therapeutics, Inc. · 2014